Securian Asset Management Inc trimmed its stake in Waters Co. (NYSE:WAT) by 1.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,418 shares of the medical instruments supplier’s stock after selling 101 shares during the period. Securian Asset Management Inc’s holdings in Waters were worth $1,597,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Thor Advisors LLC acquired a new position in Waters during the 1st quarter valued at about $64,000. Amica Retiree Medical Trust acquired a new position in Waters during the 2nd quarter valued at about $69,000. Whittier Trust Co. increased its position in Waters by 23.0% during the 1st quarter. Whittier Trust Co. now owns 369 shares of the medical instruments supplier’s stock valued at $93,000 after buying an additional 69 shares in the last quarter. Parallel Advisors LLC increased its position in Waters by 285.7% during the 1st quarter. Parallel Advisors LLC now owns 405 shares of the medical instruments supplier’s stock valued at $102,000 after buying an additional 300 shares in the last quarter. Finally, Smithfield Trust Co. increased its position in Waters by 34.1% during the 1st quarter. Smithfield Trust Co. now owns 492 shares of the medical instruments supplier’s stock valued at $124,000 after buying an additional 125 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.
Shares of WAT opened at $204.96 on Friday. Waters Co. has a 52 week low of $167.93 and a 52 week high of $255.21. The company has a quick ratio of 2.07, a current ratio of 2.65 and a debt-to-equity ratio of 2.00. The company has a market capitalization of $14.03 billion, a price-to-earnings ratio of 24.72, a PEG ratio of 2.35 and a beta of 1.07. The stock’s 50-day moving average price is $212.89 and its 200-day moving average price is $223.28.
Several research analysts recently issued reports on the company. Wolfe Research assumed coverage on Waters in a research report on Thursday, May 30th. They set an “underperform” rating on the stock. Zacks Investment Research upgraded Waters from a “sell” rating to a “hold” rating and set a $217.00 price target on the stock in a research note on Wednesday, May 22nd. ValuEngine downgraded Waters from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Cleveland Research downgraded Waters from a “neutral” rating to an “underperform” rating in a research note on Wednesday, June 12th. Finally, Bank of America downgraded Waters from a “neutral” rating to an “underperform” rating in a research note on Tuesday, July 16th. Five investment analysts have rated the stock with a sell rating, eight have issued a hold rating and one has issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $210.54.
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Article: What are benefits of a growth and income fund?
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.